Comparing two ablation methods for early-stage lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study compares two ways to destroy early-stage lung cancer without surgery: one using a needle through the chest (CT-guided) and another using a thin tube through the mouth (bronchoscopy-guided). It might be an option if you have small, outer-edge lung cancer and cannot or prefer not to have surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have early-stage (Stage IA) lung cancer that is in the outer part of the lung (peripheral) and has been confirmed by a biopsy.
- You cannot have surgery or have decided not to have surgery, and you are willing to have ablation (a procedure that destroys cancer cells with heat or cold).
- You are not on blood thinners (unless you can stop them safely for 5–7 days), and you do not have severe bleeding problems.
- You do not have severe lung scarring, active infections, or other serious health conditions that would make the procedure unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of radiofrequency ablation (a heat-based treatment) for early-stage lung cancer that is located in the outer parts of the lung. One approach uses a needle through the chest wall, the other uses a bronchoscope through the airways. The goal is to see which works better for people who cannot have surgery.
This trial tests a minimally invasive procedure using microwave energy to destroy small lung tumors, guided by a thin tube through the airways. It may be an option if you can't have standard surgery or radiation, or choose not to.
This trial tests a new treatment that uses short electrical pulses (pulsed electric field ablation) to destroy small lung tumors. It may be an option for people with limited, early-stage non-small cell lung cancer who can tolerate a minimally invasive procedure.
This trial compares two ways to freeze and destroy small lung tumors: through the chest wall or through the airways. It’s for people with early-stage lung cancer who are not able or willing to have surgery.
This study looks at two ways to treat early-stage lung cancer: using heat from a tiny probe passed through the airways to kill the tumor (microwave ablation), or surgery to remove the tumor and some surrounding tissue. The goal is to find which approach is more effective and safer for people with this type of lung cancer.
This study tests a new, less invasive way to treat lung cancer using microwave energy delivered through a thin tube inserted into the airway. It is for people with small, confirmed lung tumors who are already being considered for surgery, and who cannot or prefer not to have blood thinners.
Hear when a new Stage IA Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.